Aspen Pharmacare Holdings Limited (JSE:APN)
South Africa flag South Africa · Delayed Price · Currency is ZAR · Price in ZAc
15,701
-163 (-1.03%)
Sep 25, 2026, 5:00 PM SAST

Aspen Pharmacare Holdings Cash Flow Statement

Millions ZAR. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
2,647-1,0834,4045,2286,488
Depreciation & Amortization
1,9171,7531,6281,4551,373
Other Amortization
-336345333340
Loss (Gain) From Sale of Assets
-22341-1,212
Asset Writedown & Restructuring Costs
-4,8061,6671,9861,573
Stock-Based Compensation
-10911713558
Provision & Write-off of Bad Debts
-27211--
Other Operating Activities
-1,484547-1,739-260-594
Change in Accounts Receivable
--773-104327-1,355
Change in Inventory
--704200-2,701-2,168
Change in Accounts Payable
--126-338-984871
Change in Other Net Operating Assets
-240----
Operating Cash Flow
6,8695,1596,2255,5205,374
Operating Cash Flow Growth
33.15%-17.12%12.77%2.72%-21.26%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-2,141-2,576-3,117-2,230-1,963
Sale of Property, Plant & Equipment
-341351,830
Cash Acquisitions
--229-4,350-626-2,188
Divestitures
-1576945279434
Sale (Purchase) of Intangibles
-889-2,451-2,416-947-409
Investment in Securities
--5238-
Other Investing Activities
27,523--59560135
Investing Cash Flow
24,336-5,216-9,468-3,421-2,161

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Long-Term Debt Issued
5889,88013,9887,93914,208
Long-Term Debt Repaid
-20,474-8,373-8,784-6,768-15,831
Lease Payments
-192-205-201-183-170
Net Debt Issued (Repaid)
-19,8861,5075,2041,171-1,623
Repurchase of Common Stock
-480-68-56-136-1,857
Common Dividends Paid
-941-1,601-1,525-1,455-1,196
Financing Cash Flow
-21,307-1623,623-420-4,676

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
-332-592-653843479
Net Cash Flow
9,566-811-2732,522-984

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
4,7282,5833,1083,2903,411
Free Cash Flow Growth
83.04%-16.89%-5.53%-3.55%-28.64%
Free Cash Flow Margin
13.56%5.96%6.95%8.08%8.83%
Free Cash Flow Per Share
10.655.827.007.417.53
Levered Free Cash Flow
2,678-177.63260.51,776-261.63
Unlevered Free Cash Flow
3,644894.251,6852,628256.5
Free Cash Flow After Leases
4,5362,3782,9073,1073,241

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
1,6211,6492,2271,324765
Cash Income Tax Paid
9101,7572,1491,6141,691
Change in Working Capital
-240-1,603-242-3,358-2,652